SAN FRANCISCO - Remember leptin? The once-ballyhooed hormone and its receptor technology that Amgen Inc. licensed from Progenitor Inc. way back in 1997 had gained the limelight as a potential obesity cure two years earlier. (BioWorld Financial Watch)